Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
Pharmacology
[키워드] approved drugs
Bronchoalveolar lavage fluid
Cell
Combination
contribute
Control
correlated
COVID-19
COVID-19 patients
CRS
cytokine
cytokine production
Cytokine release syndrome
Cytokine storm
downregulating
drug
Drug repurposing
Efficacy
expression data
Factor
FDA approved Drugs
Gene regulatory networks
hospitalized COVID-19 patients
identify
Inflammatory cytokine
inflammatory cytokine production
inhibited
Interaction
interactions
investigated
involved
Pathogenesis
regimen
Release
resource
SARS-CoV2
significantly
single-cell RNA-seq
synergistic
target
targeting
TFS
the disease
therapeutic
therapeutic effect
therapeutic targeting
transcription factor
transcriptional regulator
transcriptional regulators
treat
upregulated
[DOI] 10.3389/fphar.2021.673485 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.673485 PMC 바로가기 [Article Type] Pharmacology